| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.915290 |
| 003 | CaOODSP |
| 005 | 20221101123821 |
| 006 | m o d f |
| 007 | cr mn||||||||| |
| 008 | 220909e202209 onc ob f000 0 eng d |
| 020 | |a9780660454047 |q(report) |
| 020 | |a9780660454054 |q(summary) |
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
| 043 | |an-cn--- |
| 086 | 1 |aHP40-323/2022E-PDF |
| 086 | 1 |aHP40-323/2022-1E-PDF |
| 245 | 00|aNACI rapid response : |bupdated interim guidance on Imvamune® in the context of ongoing monkeypox outbreaks. |
| 246 | 3 |aNational Advisory Committee on Immunization rapid response : |bupdated interim guidance on Imvamune® in the context of ongoing monkeypox outbreaks |
| 264 | 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cSeptember 2022. |
| 264 | 4|c©2022 |
| 300 | |a1 online resource (27 pages) + |esummary (7 pages) |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 500 | |aIssued also in French under title: Réponse rapide du CCNI : mise à jour des directives provisoires sur l'Imvamuneᴹᴰ dans le contexte des éclosions actuelles de variole simienne. |
| 500 | |aOn cover: An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI). |
| 500 | |a"Pub.: 220414." |
| 500 | |a"Pub.: 220416." |
| 504 | |aIncludes bibliographical references (pages 20-23). |
| 650 | 0|aHuman monkeypox|xVaccination|zCanada. |
| 650 | 0|aHuman monkeypox|xVaccination|xGovernment policy|zCanada. |
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
| 710 | 1 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body. |
| 775 | 08|tRéponse rapide du CCNI : |w(CaOODSP)9.915289 |
| 856 | 40|qPDF|s1.53 MB|uhttps://publications.gc.ca/collections/collection_2022/aspc-phac/HP40-323-2022-eng.pdf|z(report) |
| 856 | 40|qPDF|s1.25 MB|uhttps://publications.gc.ca/collections/collection_2022/aspc-phac/HP40-323-2022-1-eng.pdf|z(summary) |
| 986 | |a220414 |
| 986 | |a220416 |